Plus more good news for obesity drugs, which is bad news for those who question the meds' value
Plus extended thoughts on the intersection between a GAO report, insulin legislation, and the weird state of Humira biosims
And CF Treatment Has Come So Far That Make-a-Wish Won't Automatically Accept Wishes from Those With CF
As well as a call for trips and tricks for towing a UHaul 1,600 miles
Plus Adam Fein's PBM numbers, a bizarre Leqembi forecast from CMS, gene therapy reimbursement, and more ...
And a reasonable story about a drug price increase fills me with warm feelings
A short, overcaffeinated newsletter because I'm at the Tufts CEVR meeting today
Plus an update on the USA Hockey championships, some 340B links, and Cuban claps back
Plus a mention of Trump, a reference to Mark Cuban, some GLP-1 hits, a 340B item, and a Wire reference
Plus a must-read STAT piece on how to think about GLP-1s
And a nice STAT explainer on 'bridge programs'
Plus a STAT story that suggests that regulatory bodies are not ready for drug development circa 2024
